These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6799536)
1. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. Chang RJ; Mandel FP; Lu JK; Judd HL J Clin Endocrinol Metab; 1982 Mar; 54(3):490-4. PubMed ID: 6799536 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505 [TBL] [Abstract][Full Text] [Related]
3. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501 [TBL] [Abstract][Full Text] [Related]
4. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome. Judd HL; Rigg LA; Anderson DC; Yen SS J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366 [TBL] [Abstract][Full Text] [Related]
5. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. Dunaif A; Mandeli J; Fluhr H; Dobrjansky A J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783 [TBL] [Abstract][Full Text] [Related]
6. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. Lasley BL; Wang CF; Yen SS J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551 [TBL] [Abstract][Full Text] [Related]
8. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone. Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389 [TBL] [Abstract][Full Text] [Related]
9. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. Lobo RA; Granger L; Goebelsmann U; Mishell DR J Clin Endocrinol Metab; 1981 Jan; 52(1):156-8. PubMed ID: 6778890 [TBL] [Abstract][Full Text] [Related]
10. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705 [TBL] [Abstract][Full Text] [Related]
11. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease. Christman GM; Randolph JF; Kelch RP; Marshall JC J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845 [TBL] [Abstract][Full Text] [Related]
12. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF). Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076 [TBL] [Abstract][Full Text] [Related]
13. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031 [TBL] [Abstract][Full Text] [Related]
14. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action. Richardson DW; Gordon K; Billiar RB; Little AB Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275 [TBL] [Abstract][Full Text] [Related]
15. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. Spinder T; Spijkstra JJ; van den Tweel JG; Burger CW; van Kessel H; Hompes PG; Gooren LJ J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710 [TBL] [Abstract][Full Text] [Related]
16. Responses of serum gonadotrophins to LH-releasing hormone and oestrogens in Japanese women with polycystic ovaries. Aono T; Miyazaki M; Miyake A; Kinugasa T; Kurachi K; Matsumoto K Acta Endocrinol (Copenh); 1977 Aug; 85(4):840-9. PubMed ID: 196471 [TBL] [Abstract][Full Text] [Related]
17. Pituitary and ovarian responses to LHRH stimulation in women with clinical features of the polycystic ovary syndrome. Heineman MJ; Thomas CM; Doesburg WH; Rolland R Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):273-84. PubMed ID: 6430731 [TBL] [Abstract][Full Text] [Related]
18. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. Chang RJ; Laufer LR; Meldrum DR; DeFazio J; Lu JK; Vale WW; Rivier JE; Judd HL J Clin Endocrinol Metab; 1983 May; 56(5):897-903. PubMed ID: 6403570 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of bromocriptine on gonadotropin secretion in polycystic ovary syndrome. Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Fossati P Fertil Steril; 1985 Sep; 44(3):356-60. PubMed ID: 3161758 [TBL] [Abstract][Full Text] [Related]
20. Progesterone effects on gonadotropin release in women pretreated with estradiol. Chang RJ; Jaffe RB J Clin Endocrinol Metab; 1978 Jul; 47(1):119-25. PubMed ID: 122395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]